- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
U.S. number of venture capital deals for infectious disease companies 2006-2018
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
U.S. number of venture capital deals for infectious disease companies 2006-2018
Number of venture capital deals for infectious disease companies in the U.S. from 2006 to 2018
by Matej Mikulic,
last edited
Sep 4, 2019
In 2018, there were 19 venture capital deals in the infectious disease branch in the United States. This graph shows the total number of venture capital deals for infectious disease companies in the U.S. from 2006 to 2018. Within the given period, 2018 was the year with the lowest number of such venture capital deals.
Number of venture capital deals for infectious disease companies in the U.S. from 2006 to 2018
| Number of venture capital deals | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Number of venture capital deals | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Sep 4, 2019
In 2018, there were 19 venture capital deals in the infectious disease branch in the United States. This graph shows the total number of venture capital deals for infectious disease companies in the U.S. from 2006 to 2018. Within the given period, 2018 was the year with the lowest number of such venture capital deals.
- Show sources information
- Show publisher information
- Release date
- 2019
- Region
- United States
- Survey time period
- 2006 to 2018
- Supplementary notes
- * Added from previous editions of the same report.
Source
- Show sources information
- Show publisher information
- Release date
- 2019
More information
- Region
- United States
- Survey time period
- 2006 to 2018
- Supplementary notes
- * Added from previous editions of the same report.
Other statistics on the topic
+Pharmaceutical Products & Market
Leading pharmaceutical companies in Norway 2018, by turnover
+Pharmaceutical Products & Market
Value of pharmaceutical sales in Norway 2000-2017
+Pharmaceutical Products & Market
Leading pharmaceutical companies in Norway 2018, by market share
+Pharmaceutical Products & Market
Pharmaceutical preparations: manufacturing turnover in Norway 2007-2015
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
Statistics on "Pharmaceutical industry in Norway "
- Overview
The most important statistics
- Value of pharmaceutical sales in Norway from 2000 to 2017 (in milllion NOK) Value of pharmaceutical sales in Norway 2000-2017
- Leading pharmaceutical companies in Norway in 2018, by turnover (in million NOK) Leading pharmaceutical companies in Norway 2018, by turnover
- Leading pharmaceutical companies in Norway in 2018, by market share Leading pharmaceutical companies in Norway 2018, by market share
- Producer price index (PPI) of chemical and pharmaceutical products in Norway from 2008 to 2018producer price index of chemical and pharmaceutical products in Norway 2008-2018
- Public expenditure on blue prescriptions* in Norway from 2013 to 2018 (in billion NOK) Public expenditure on blue prescriptions in Norway 2013-2018
- Number of pharmaceuticals available in Norway from 2013 to 2018 Number of pharmaceuticals available in Norway 2013-2018
- Leading nonprescription pharmaceutical companies in Norway in 2018, by market share Leading nonprescription pharmaceutical companies in Norway 2018, by market share
- Production and trade
The most important statistics
- Turnover of pharmaceutical preparation manufacturers in Norway from 2007 to 2015 (in million NOK)Pharmaceutical preparations: manufacturing turnover in Norway 2007-2015
- Number of establishments in the manufacture of pharmaceutical preparations industry in Norway from 2007 to 2017Number of pharmaceutical preparation establishments in Norway 2007-2017
- Number of employees in the manufacture of pharmaceutical preparations industry in Norway from 2007 to 2017Number of employees in pharmaceutical industry in Norway 2007-2017
- Import and export value of basic pharmaceutical products and pharmaceutical preparations in Norway in 2018 (in million NOK)Import and export value of basic pharmaceuticals in Norway 2018
- Import value of basic pharmaceutical products and pharmaceutical preparations into Norway from 2008 to 2018 (in million NOK)Import value of basic pharmaceuticals and preparations into Norway 2008-2018
- Export value of basic pharmaceutical products and pharmaceutical preparations from Norway from 2008 to 2018 (in million NOK)Export value of basic pharmaceuticals and preparations from Norway 2008-2018
- Pharmaceutical turnover
The most important statistics
- Turnover share of prescription pharmaceuticals in Norway in 2017, by prescription type (in million NOK) Turnover share of prescription drugs in Norway 2017, by prescription type
- Turnover of pharmaceuticals in Norway in 2017, by prescription type (in million NOK) Turnover of pharmaceuticals in Norway 2017, by prescription type
- Turnover share of generic pharmaceuticals in Norway from 2013 to 2018 (in DDD*) Turnover share of generic pharmaceuticals in Norway 2013-2018
- Turnover of pharmaceuticals in Norway in 2017, by type of drug (in million NOK)Turnover of pharmaceuticals in Norway 2017, by type of drug
- Turnover of pharmaceuticals in Norway in 2017, by ATC main groups (in million NOK) Turnover of pharmaceuticals in Norway 2017, by ATC main groups
- Turnover of nonprescription drugs in Norway from 2014 to 2018 (in million NOK) Turnover of nonprescription drugs in Norway 2014-2018
- R&D, patents and new products
The most important statistics
- Number of patents in the biotechnology sector in Norway from 2011 to 2017Number of biotechnology patents in Norway 2011-2017
- Number of applications for clinical trials in Norway from 2013 to 2018Number of applications for clinical trials in Norway 2013-2018
- Number of applications for clinical trials in Norway from 2013 to 2018, by type of actor Number of applications for clinical trials in Norway 2013-2018, by type of actor
- Volume share of pharmaceutical sales Norway in 2016, by introduction date Volume share of pharmaceutical sales in Norway 2016, by introduction date
- Number of new cancer pharmaceuticals approved by the European Medicines Agency (EMA) in Norway from 2014 to 2017 Number of new cancer pharmaceuticals approved by EMA in Norway 2014-2017
- Number of new and expired active substances in Norway from 2013 to 2018 Number of new and expired active substances in Norway 2013-2018
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- U.S. venture investments in infectious disease companies 2006-2018
- U.S. number of venture capital deals for neurology companies 2006-2018
- U.S. infectious disease company IPO financing 2006-2018
- U.S. infectious disease company IPOs 2006-2018
- U.S. venture funding of therapeutic companies by disease type 2018
- U.S. number of venture capital deals for psychiatry companies 2006-2018
- U.S. number of venture capital deals for oncology companies 2006-2018
- U.S. venture investments in psychiatry companies 2006-2018
- U.S. psychiatry company IPO financing 2006-2018
- U.S. number of venture capital deals for cardiovascular companies 2006-2018
- U.S. psychiatry company IPOs 2006-2018
- U.S. venture investments in neurology companies 2006-2018
- Total infectious diseases funding by the National Institutes for Health 2013-2020
- U.S. cardiovascular company IPOs 2006-2018
- U.S. number of IPOs for neurology companies 2006-2018
- U.S. investment for emerging therapeutic companies 2009-2018
- Ranking of pharma companies by social media engagement 2014
- Global pharma companies by Facebook post comments 2012-2013
- Top 10 - pharmaceutical companies based on revenue in 2006
- Net profits of leading pharmaceutical companies
Studies
- Pharmaceutical trends in Europe
- Indicatori Farmaceutici
- Pharmaceutical industry in India
- Pharmaceutical industry in Italy
- Pharmaceutical industry in Japan
- Pharmaceutical industry in China
- Vaccine industry in China
- Generic Pharmaceutical Industry Yearbook 2016
- Tackling drug-resistant infections globally: the review on antimicrobial resistance
- Great Expectations: Why Pharma Companies Can’t Ignore Patient Services
- 2019 PhRMA Annual Membership Survey
- Medtronic - 2019 Form 10-K
- California Life Sciences Industry Report 2019
- Teva - 2018 Form 10-K
- Boehringer Ingelheim - Annual Report 2018
Statistics on "Pharmaceutical industry in Norway "
- Value of pharmaceutical sales in Norway from 2000 to 2017 (in milllion NOK)
- Leading pharmaceutical companies in Norway in 2018, by turnover (in million NOK)
- Leading pharmaceutical companies in Norway in 2018, by market share
- Producer price index (PPI) of chemical and pharmaceutical products in Norway from 2008 to 2018
- Public expenditure on blue prescriptions* in Norway from 2013 to 2018 (in billion NOK)
- Number of pharmaceuticals available in Norway from 2013 to 2018
- Leading nonprescription pharmaceutical companies in Norway in 2018, by market share
- Turnover of pharmaceutical preparation manufacturers in Norway from 2007 to 2015 (in million NOK)
- Number of establishments in the manufacture of pharmaceutical preparations industry in Norway from 2007 to 2017
- Number of employees in the manufacture of pharmaceutical preparations industry in Norway from 2007 to 2017
- Import and export value of basic pharmaceutical products and pharmaceutical preparations in Norway in 2018 (in million NOK)
- Import value of basic pharmaceutical products and pharmaceutical preparations into Norway from 2008 to 2018 (in million NOK)
- Export value of basic pharmaceutical products and pharmaceutical preparations from Norway from 2008 to 2018 (in million NOK)
- Turnover share of prescription pharmaceuticals in Norway in 2017, by prescription type (in million NOK)
- Turnover of pharmaceuticals in Norway in 2017, by prescription type (in million NOK)
- Turnover share of generic pharmaceuticals in Norway from 2013 to 2018 (in DDD*)
- Turnover of pharmaceuticals in Norway in 2017, by type of drug (in million NOK)
- Turnover of pharmaceuticals in Norway in 2017, by ATC main groups (in million NOK)
- Turnover of nonprescription drugs in Norway from 2014 to 2018 (in million NOK)
- Number of patents in the biotechnology sector in Norway from 2011 to 2017
- Number of applications for clinical trials in Norway from 2013 to 2018
- Number of applications for clinical trials in Norway from 2013 to 2018, by type of actor
- Volume share of pharmaceutical sales Norway in 2016, by introduction date
- Number of new cancer pharmaceuticals approved by the European Medicines Agency (EMA) in Norway from 2014 to 2017
- Number of new and expired active substances in Norway from 2013 to 2018
- Venture investments in infectious disease companies in the U.S. from 2006 to 2018 (in million U.S. dollars)
- Number of venture capital deals for neurology companies in the U.S. from 2006 to 2018
- Amount raised through initial public offerings (IPOs) from infectious disease companies in the U.S. from 2006 to 2018 (in million U.S. dollars)*
- Number of initial public offerings (IPOs) from companies in infectious disease in the U.S. from 2006 to 2018*
- Venture funding of U.S. therapeutic companies in 2018, by disease type (in million U.S. dollars)
- Number of venture capital deals for psychiatry companies in the U.S. from 2006 to 2018
- Number of venture capital deals for oncology companies in the U.S. from 2006 to 2018
- Venture investments in psychiatry companies in the U.S. from 2006 to 2018 (in million U.S. dollars)
- Amount raised through initial public offerings (IPOs) from psychiatry companies in the U.S. from 2006 to 2018 (in million U.S. dollars)*
- Number of venture capital deals for cardiovascular companies in the U.S. from 2006 to 2018
- Number of initial public offerings (IPOs) from psychiatry companies in the U.S. from 2006 to 2018*
- Venture investments in neurology companies in the U.S. from 2006 to 2018 (in million U.S. dollars)
- Total infectious diseases funding by the National Institutes for Health (NIH) from FY 2013 to FY 2020 (in million U.S. dollars)
- Number of initial public offerings (IPOs) for cardiovascular companies in the U.S. from 2006 to 2018*
- Number of initial public offerings (IPOs) for neurology companies in the U.S. from 2006 to 2018*
- Investment for emerging therapeutic companies in the U.S. between 2009 and 2018 (in billion U.S. dollars)
- Top 10 pharmaceutical companies ranked by IMS Health Social Media Engagement Index as of 2014
- Average number of comments per Facebook post of selected top pharma companies in 2012 and 2013
- Top 10 of the world's pharmaceutical companies based on revenue in 2006 (in billion euros)
- Net profits of leading pharmaceutical companies in Q3 2010 (in million U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.